INS and obesity disorder: For example, Lin et al. [23] found that pharmacological promotion of autophagy by rapamycin and carbamazepine protected against fatty liver pathologies by regulating lipid metabolism, reducing triglyceride levels, and improving insulin sensitivity in mice with HFD-induced obesity.